We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · November 11, 2021

First-Line Combination ICI and Targeted Therapy for Melanoma Brain Metastases

European Journal of Cancer


Additional Info

European Journal of Cancer
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
Eur. J. Cancer 2021 Oct 01;156(xx)149-163, ML Hilbers, F Dimitriou, P Lau, P Bhave, GA McArthur, L Zimmer, K Kudura, CL Gérard, MP Levesque, O Michielin, R Dummer, PF Cheng, J Mangana

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading